A group of scientists working across South Korea, Massachusetts and Texas have developed a transparent wrist cuff that's means to be worn as a non-invasive blood sugar monitor and treatment.
When this device is worn, it is capable of measuring glucose levels in the bloodstream and from there, a diabetic patient is able to receive a low drug dosage via microneedles if the smart band deems that it is needed. Unlike many other solutions, this design is meant to be extremely non-invasive and painless.
For these abilities, the device is being likened to a "robotic pancreas" that is able to sense and treat spikes or dips in glucose levels. While this is not a solution for extreme blood sugar activity, this wearable device could seamlessly become part of a diabetic's daily life.
What's Driving This Trend
- Transparent Blood Sugar Monitoring
- There is a disruptive innovation opportunity in developing transparent wrist cuffs that can accurately monitor blood sugar levels non-invasively and painlessly.
- Smart Wristband Drug Delivery
- Developing smart wristbands with microneedles that can deliver low drug dosages based on glucose level measurements presents a disruptive innovation opportunity in the healthcare industry.
- Robotic Pancreas Wearables
- Creating wearable devices that mimic the function of a pancreas by sensing and treating fluctuations in glucose levels represents a disruptive innovation opportunity for healthcare technology.
Who This Affects Most
- Healthcare Technology
- The healthcare technology industry can explore the development of transparent blood sugar monitoring wristbands and robotic pancreas wearables for diabetic patients.
- Wearable Technology
- The wearable technology industry can capitalize on the demand for smart wristbands that offer non-invasive blood sugar monitoring and drug delivery capabilities.
- Pharmaceuticals
- The pharmaceutical industry can explore collaborations and partnerships to develop low-dosage drug formulations suitable for smart wristband delivery systems.
